Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has received 510(k) clearance from the United States Food & Drug Administration for a stemless anatomic total ...

Smith+Nephew has received 510(k) clearance from the United States Food & Drug Administration for a stemless anatomic total shoulder for the AETOS Shoulder System. AETOS Stemless addresses the ...

Smith & Nephew is to relocate to a new £80m site in Melton, eight miles (13km) from its current factory. The medical equipment maker employs around 800 people and has been based in Hull since it ...

Three of Smith & Nephew’s biggest shareholders are reportedly urging the FTSE 100 firm to break up if it cannot improve performance. The top 20 investors called on the London-based medical ...

Smith & Nephew plc, a global medical technology company, has announced its total issued share capital consists of 877,704,186 ordinary shares as of December 31, 2024, with 874,387,717 shares ...

Please provide your email address to receive an email when new articles are posted on . Smith & Nephew received FDA clearance of its Coriograph preoperative planning and modeling solution for use ...

If you continue to have this issue please contact [email protected]. Smith & Nephew received FDA 510(k) clearance of a stemless option for its Aetos shoulder system. The solution is ...